Rothschild & Co Asset Management US’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-309,967
Closed -$8.38M 578
2016
Q1
$8.38M Buy
309,967
+7,094
+2% +$203K 0.16% 207
2015
Q4
$9.13M Buy
302,873
+15,149
+5% +$486K 0.17% 199
2015
Q3
$9.1M Buy
287,724
+19,984
+7% +$730K 0.18% 192
2015
Q2
$10.4M Buy
267,740
+226,560
+550% +$7.81M 0.19% 185
2015
Q1
$1.46M Buy
+41,180
New +$1.33M 0.03% 315

Other funds holding PAHC

Rothschild & Co Asset Management US's PAHC Position: Q2 2016 in Review

Rothschild & Co Asset Management US sold out of Phibro Animal Health (PAHC) in Q2 2016, closing a stake of 309,967 shares — an estimated $8.38M sold.

Rothschild & Co Asset Management US first reported a position in PAHC in Q1 2015 and held it in 5 quarters. The position peaked at $10.4M in Q2 2015. 123 funds tracked by Wall St. Rank hold PAHC as of Q2 2016.

  • Rothschild & Co Asset Management US reported no remaining Phibro Animal Health position as of Q2 2016 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 309,967 Phibro Animal Health shares in Q2 2016, an estimated $8.38M.
  • Rothschild & Co Asset Management US first reported a position in Phibro Animal Health in Q1 2015 and held it in 5 quarters.
  • Rothschild & Co Asset Management US's Phibro Animal Health position peaked at $10.4M in Q2 2015.
  • 123 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2016.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2016, filed 3 Aug 2016.